Premium
Pathogenesis and management of myocardial injury in coronavirus disease 2019
Author(s) -
Wei ZhiYao,
Geng YongJian,
Huang Ji,
Qian HaiYan
Publication year - 2020
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.1967
Subject(s) - medicine , pandemic , covid-19 , intensive care medicine , epidemiology , coronavirus , disease , outbreak , transmission (telecommunications) , incubation period , pathogenesis , virology , infectious disease (medical specialty) , biochemistry , chemistry , incubation , electrical engineering , engineering
The outbreak of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a major health crisis and a worldwide pandemic. COVID‐19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and strong transmission intensity. COVID‐19 can cause myocardial injury as well as other cardiovascular complications, particularly in senior patients with pre‐existing medical conditions. The current review summarizes the epidemiological characteristics, potential mechanisms, clinical manifestations, and recent progress in the management of COVID‐19 cardiovascular complications.